Gastrointestinal Diseases  >>  BIIB022  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BIIB022 / Biogen
NCT00956436: Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Completed
1b
40
US, Europe, RoW
BIIB022, IGF-1R, Liver Cancer, Hepatocellular Carcinoma, Monoclonal Antibody, Sorafenib, HCC, Nexavar
Biogen
Hepatocellular Carcinoma
04/11
04/11

Download Options